IPCARF: improving lncRNA-disease association prediction using incremental principal component analysis feature
Rong Zhu1,2, Yong Wang3, Jin-Xing Liu1
1School of Computer Science, Qufu Normal University, Rizhao, China.
BMC Bioinformatics
|April 2, 2021
Summary
A new computational method, IPCARF, effectively predicts long non-coding RNA (lncRNA)-disease associations using integrated machine learning. This approach improves upon existing methods for identifying potential disease biomarkers.
Area of Science:
- Computational biology
- Genomics
- Biomedical informatics
Background:
- Identifying long non-coding RNA (lncRNA)-disease associations is crucial for understanding disease mechanisms and discovering biomarkers.
- Traditional experimental methods struggle to keep pace with the growing volume of biological data for lncRNA-disease association detection.
- Developing effective computational methods is essential for predicting human lncRNA-disease associations.
Purpose of the Study:
- To propose a novel computational algorithm, IPCARF, for predicting lncRNA-disease associations.
- To integrate multiple similarity matrices and machine learning techniques for enhanced prediction accuracy.
Main Methods:
- Developed the IPCARF algorithm combining incremental principal component analysis (IPCA) and random forest (RF).
- Computed disease semantic similarity using a directed acyclic graph and integrated lncRNA similarity and Gaussian nuclear similarity.
- Reduced feature dimensionality using IPCA and trained an RF model for prediction.
Main Results:
- The IPCARF algorithm demonstrated improved prediction performance, achieving an Area Under the Curve (AUC) of 0.8529 before parameter optimization.
- After grid search optimization, the IPCARF algorithm's AUC reached 0.8611.
- IPCARF effectively improved the AUC metric for predicting potential lncRNA-disease associations.
Conclusions:
- The IPCARF method shows superior performance compared to existing prediction methods like LRLSLDA, LRLSLDA-LNCSIM, TPGLDA, NPCMF, and ncPred.
- IPCARF provides a more accurate and efficient approach for predicting lncRNA-disease associations.
- The study highlights the potential of integrated machine learning for advancing lncRNA-disease association research.
Related Concept Videos
lncRNA - Long Non-coding RNAs
9.3K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
Cancer Survival Analysis
508
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
508
Non-LTR Retrotransposons
12.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.5K


